181 related articles for article (PubMed ID: 38222252)
21. Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Chao TF; Tse HF; Teo WS; Park HW; Shimizu W; Chen SA; Lip GYH;
Eur J Clin Invest; 2022 Oct; 52(10):e13825. PubMed ID: 35700114
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry.
Ding WY; Proietti M; Boriani G; Fauchier L; Blomström-Lundqvist C; Marin F; Potpara TS; Lip GYH;
Europace; 2022 May; 24(5):721-728. PubMed ID: 35446354
[TBL] [Abstract][Full Text] [Related]
24. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry.
Ding WY; Blomström-Lundqvist C; Fauchier L; Marin F; Potpara TS; Boriani G; Lip GYH
Europace; 2023 Feb; 25(2):277-282. PubMed ID: 36427202
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Gao X; Cai X; Yang Y; Zhou Y; Zhu W
Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
[No Abstract] [Full Text] [Related]
26. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
[TBL] [Abstract][Full Text] [Related]
27. [A comparison of CAS risk model and CHA
Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
[No Abstract] [Full Text] [Related]
28. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
[TBL] [Abstract][Full Text] [Related]
29. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH
Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920
[TBL] [Abstract][Full Text] [Related]
30. Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.
Guo Y; Apostolakis S; Blann AD; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Sep; 168(2):904-9. PubMed ID: 23167998
[TBL] [Abstract][Full Text] [Related]
31. Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries.
Proietti M; Laroche C; Nieuwlaat R; Crijns HJGM; Maggioni AP; Lane DA; Boriani G; Lip GYH; ;
Eur J Intern Med; 2018 Sep; 55():28-34. PubMed ID: 29778588
[TBL] [Abstract][Full Text] [Related]
32. Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.
Chichareon P; Winijkul A; Lip GYH; Krittayaphong R
Br J Clin Pharmacol; 2023 Aug; 89(8):2472-2482. PubMed ID: 36942465
[TBL] [Abstract][Full Text] [Related]
33. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
Fox KAA; Virdone S; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Oto A; Misselwitz F; Piccini JP; Dalgaard F; Turpie AGG; Verheugt FWA; Kakkar AK;
Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):214-227. PubMed ID: 33892489
[TBL] [Abstract][Full Text] [Related]
34. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.
Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GYH;
Europace; 2019 Jul; 21(7):1013-1022. PubMed ID: 30904925
[TBL] [Abstract][Full Text] [Related]
35. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
36. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
37. Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
Dan GA; Badila E; Weiss E; Laroche C; Boriani G; Dan A; Tavazzi L; Maggioni AP; Crijns HJ; Popescu R; Blommaert D; Streb W; Lip GYH;
Int J Cardiol; 2018 Mar; 254():136-141. PubMed ID: 29407080
[TBL] [Abstract][Full Text] [Related]
38. Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHA
Methavigul K; Chichareon P; Yindeengam A; Krittayaphong R
BMC Cardiovasc Disord; 2023 Dec; 23(1):623. PubMed ID: 38114960
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry.
Ding WY; Boriani G; Marin F; Blomström-Lundqvist C; Potpara TS; Fauchier L; Lip GYH;
Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):372-382. PubMed ID: 34665249
[TBL] [Abstract][Full Text] [Related]
40. Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry.
Pérez Cabeza AI; Rivera-Caravaca JM; Roldán-Rabadán I; García Seara J; Bertomeu-Gonzalez V; Leal M; García-Fernandez A; Tercedor Sanchez L; Ayarra M; Ciudad M; Castaño S; Maestre A; Anguita M; Garcia Bolao I; Marín F
Eur J Clin Invest; 2022 Apr; 52(4):e13709. PubMed ID: 34757635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
